J&J bags option on AdoRx lung cancer drugs - FierceBiotech

J&J bags option on AdoRx lung cancer drugs  FierceBiotech

Johnson & Johnson Is teaming up with AdoRx Therapeutics to develop lung cancer drugs. The deal gives J&J an exclusive option to research, develop and ...



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Respirology | APSR Respiratory Medicine Journal